Ginsenoside Rg1 reduces endothelial cell injury in transplant-associated thromboticmicroangiopathy by regulating the expression of HIF-1α
Authors:
Open Access
- 2 November 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1764090
Abstract
Purpose: Transplant-Associated Thromboticmicroangiopathy (TA-TMA) is a common complication after hematopoietic stem cell transplantation (HSCT) with poor prognosis. This study aimed to explore the role and the regulation of Hypoxia-inducible factor-1α (HIF-1α) in TA-TMA. In addition, the effect of Ginsenoside Rg1 on TA-TMA endothelial cells was also explored. Method: We constructed a TA-TMA endothelial cell model using plasma from TA-TMA patients. A TA-TMA mouse model was successfully constructed by upregulating the expression of HIF-1α using Dimethyloxallyl Glycine(DMOG) in the HSCT mice. AKT inhibitor MK2206 and STAT3 inhibitor stattic were applied to TA-TMA endothelial cells, and the expression of AKT/STAT3/HIF-1α axis was detected. Endothelial cells were divided into control group, TA-TMA group and TA-TMA+Rg1 group. The proliferation, apoptosis and related proteins expression of endothelial cells were detected. Results: A-TMA plasma leaded to the toxicity of endothelial cells. The expression of p-AKT, p-STAT3, and HIF-1α/Plasminogen Activator Inhibitor-1 (PAI-1) was significantly increased in TA-TMA endothelial cell model. The expression of p-STAT3 and HIF-1α was significantly reduced when MK2206 was used. The expression of HIF-1α was significantly reduced when stattic was used. Rg1 reduced the toxicity of TA-TMA endothelial cells, as well as significantly reducing the expression of both HIF-1α and PAI-1. Furthermore, Rg1 also reduced the expression of AKT/STAT3/HIF-1α pathway. Conclusion: The expression of HIF-1α/PAI-1 was significantly increased in TA-TMA cellular and animal models. The AKT/STAT3/HIF-1α pathway was active in TA-TMA endothelial cells. Rg1 reduced the toxicity of TA-TMA endothelial cells, especially reducing the expression of HIF-1α and PAI-1.Keywords
This publication has 58 references indexed in Scilit:
- Prolyl hydroxylase inhibitors, roxadustat and daprodustat, inhibit platelet activation and thrombosis through the PI3K/AKT/HIF-1α pathwayBiochemical Pharmacology, 2026
- HIF-1A as a prognostic biomarker related to invasion, migration and immunosuppression of cervical cancerHeliyon, 2024
- Resource equation method for sample size calculation in animal studiesThe American Journal of Emergency Medicine, 2022
- Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: Pharmacology and mechanismsBiomedicine & Pharmacotherapy, 2020
- Circulating Heme Oxygenase-1 and Complement Activation in Transplant-Associated Thrombotic MicroangiopathyTransplantation and Cellular Therapy, 2019
- Ginsenoside Rg1 Prevents Chemotherapy-Induced Cognitive Impairment: Associations with Microglia-Mediated Cytokines, Neuroinflammation, and NeuroplasticityMolecular Neurobiology, 2019
- Expression of hypoxia-inducible factor 1 alpha ameliorate myocardial ischemia in ratBiochemical and Biophysical Research Communications, 2015
- Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and functionImmunologic Research, 2012
- Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1α to promote angiogenesisAngiogenesis, 2011
- Pharmacokinetics, tissue distribution, metabolism, and excretion of ginsenoside Rg1 in ratsArchives of Pharmacal Research, 2010